4 Foot Lotions You’ll Swear by if You Have Diabetes
🧐 Did You Know? Diabetes can affect the skin’s ability to hold in moisture. Make sure to use a good lotion to keep your…
This study is for those with Type 2 Diabetes using only oral meds or no meds for their diabetes. Participants will add either a once weekly injection of CagriSema or placebo to their current treatment. CagriSema is an investigational combination medication of Cagrilinitide and Semaglutide.
The goal of the study is to see how well the investigational med, CagriSema, helps with weight loss.
Participants will receive the study med at no charge, and will be compensated for their time and travel.
To take part in the study, participants should be:
See if you qualify
CEO and Medical Director
Director of Clinical Services
Director of Clinical Research
Clinical Research Coordinator
Clinical Research Coordinator
Navigator/Study Start-up Manager
Clinical Research Coordinator
Clinical Research Coordinator